Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of PRX 302 in patients with moderate to severe benign prostatic hyperplasia

Next Previous
X
Search
Trial Profile

Phase II trial of PRX 302 in patients with moderate to severe benign prostatic hyperplasia

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Dec 2010

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Topsalysin (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use

    • Most Recent Events

    • 09 Dec 2010 According to a Protox Therapeutics media release, results of this trial plus another phase I trial [see 700014352] have been published online in European Urology.
    • 24 Nov 2009 Results presented at 30th World Congress of the Societe Internationale d'Urologie, according to a Protox media release.
    • 29 Apr 2009 Lead site (Can Med Clinical Research Centre) and lead investigator added (Pomerville P) from Protox media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top